How TNF-α Affects Malaria Development in the Liver
Author Information
Author(s): Depinay Nadya, Franetich Jean Francois, Grüner Anne Charlotte, Mauduit Marjorie, Chavatte Jean-Marc, Luty Adrian J. F., van Gemert Geert-Jan, Sauerwein Robert W., Siksik Jean-Michel, Hannoun Laurent, Mazier Dominique, Snounou Georges, Rénia Laurent
Primary Institution: Institut Cochin, Université Paris Descartes, CNRS, Paris, France
Hypothesis
What is the role of TNF-α in inhibiting the pre-erythrocytic stages of malaria parasites?
Conclusion
TNF-α treatment prevents the development of malaria pre-erythrocytic stages through the activity of a mediator that remains to be identified.
Supporting Evidence
- TNF-α treatment prevents the development of malaria pre-erythrocytic stages.
- Inhibition varies with the infecting parasite species and the type of hepatocytes used.
- The inhibitory effect is mediated by a soluble factor from TNF-α stimulated hepatocytes.
Takeaway
Researchers found that a substance called TNF-α can stop malaria parasites from growing in the liver, but it only works if given before the parasites arrive.
Methodology
The study involved testing human and mouse TNF-α against malaria parasites in various cell types to assess its inhibitory effects.
Limitations
The study's findings may not directly translate to human infections due to differences in cytokine-host cell-parasite combinations.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website